Platelet-activating factor and antagonists modulate DNA synthesis in human bone marrow stromal cell cultures

Journal of Lipid Mediators and Cell Signalling

Volumn 16, Issue 3, 1997, Pages 147-153

  Rougier, Frédéric ^a   Dupuis, Fabienne ^a   Cornu, Elisabeth ^b   Dulery, Claude ^a   Praloran, Vincent ^a   Denizot, Yves ^a  

^a UNIVERSITY OF LIMOGES   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Basic fibroblast growth factor; Human; Marrow stromal cells; PAF; Thymidine incorporation

Indexed keywords

[2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE; BASIC FIBROBLAST GROWTH FACTOR; GINKGOLIDE B; RADIOISOTOPE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; THYMIDINE;

ARTICLE; BONE MARROW CELL; CATABOLISM; CELL CULTURE; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG ANTAGONISM; DRUG METABOLISM; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; MYELOFIBROSIS; PRIORITY JOURNAL; SERUM; STROMA CELL;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; BLOOD; BONE MARROW; BONE MARROW CELLS; CELLS, CULTURED; CULTURE MEDIA; DITERPENES; DNA REPLICATION; FIBRINOLYTIC AGENTS; FIBROBLAST GROWTH FACTOR 2; GINKGOLIDES; HUMANS; LACTONES; MYELOFIBROSIS; PHOSPHOLIPASES A; PHOSPHOLIPID ETHERS; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION INHIBITORS; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; STROMAL CELLS; THYMIDINE;

EID: 0031193876     PISSN: 09297855     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-7855(97)00576-2     Document Type: Article

References (17)

1. Cazenave J.P., Benveniste J., Mustard F.J. Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane active drugs. Lab Invest. 41:1979;275-285.
2. Denizot Y., Dupuis F., Trimoreau F., Verger C., Allegraud A., Praloran V. PAF and haematopoiesis. IX. Platelet-activating factor increases DNA synthesis in human bone marrow cells. J Lipid Mediators Cell Signalling. 15:1996;1-4.
3. Denizot Y., Rougier F., Dupuis F., Verger C., Dulery C., Laskar M., Aldigier J.C., Praloran V. PAF and haematopoiesis. VIII. Biosynthesis and metabolism of platelet-activating factor by human bone marrow stromal cells. Exp Hematol. 24:1996;1327-1332.
4. Denizot Y., Trimoreau F., Dupuis F., Verger C., Praloran V. PAF and haematopoiesis. III. Presence and metabolism of platelet-activating factor in human bone marrow. Biochim Biophys Acta. 1265:1995;55-60.
5. Fixe P, Rougier F, Ostyn E, Gachard N, Faucher JL, Praloran V, Denizot Y. (1997) Spontaneous and inducible production of macrophage colony-stimulating factor by human bone marrow stromal cells. Eur Cytokine Netw `in press'.
6. Galmiche M.C., Koteliansky V.E., Brière J., Hervé P., Charbord P. Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood. 82:1993;66-76.
7. Herbert J.M., Laplace M.C., Mares A.M., Dol F. Platelet-activating factor (PAF) is not an essential component of the cascade leading to smooth muscle cell proliferation following vascular injury. J Lipid Mediators Cell Signalling. 12:1995;49-57.
8. Jouvin-Marche E., Ninio E., Beaurain G., Tencé M., Niaudet N., Benveniste J. Biosynthesis of paf-acether (platelet-activating factor). VII. Precursors of paf-acether and acetyltransferase activity in human leukocytes. J Immunol. 133:1984;892-898.
9. Kimura A., Katoh O., Kuramoto A. Effects of platelet derived growth factor, epidermal growth factor and transforming growth factor-β on the growth of human marrow fibroblasts. Br J Haematol. 69:1988;9-12.
10. Lorgeot V, Trimoreau F, Gachard N, Praloran V, Denizot Y. (1997) Leukemia inhibitory factor (LIF) concentrations in the bone marrow plasma of healthy subjects and patients with hematologic malignancies. Eur Cytokine Netw `in press'.
11. Mayani H., Guilbert L.J., Janowska-Wieczorek A. Biology of the hemopoietic microenvironment. Eur J Haematol. 49:1992;225-233.
12. Miwa M., Miyake T., Yamanaka T., Sugatani J., Suzuki Y., Sakata S., Araki Y., Matsumoto M. Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J Clin Invest. 82:1988;1983-1991.
13. Stafforini D.M., Prescott S.M., Zimmerman G.A., McIntyre T.M. Platelet-activating factor acetylhydrolase activity in human tissues and blood cells. Lipids. 26:1991;979-985.
14. Stoll L.L., Figard P.H., Yerram N.R., Yorek M.A., Spector A.A. 1-O-alkyl-2-acetyl-sn-glycerol: a platelet-activating factor metabolite with biological activity in vascular smooth muscle cells. Cell Regulation. 1:1989;13-25.
15. Tomlinson P.R., Croft K., Harris T., Stewart A.G. Platelet-activating factor biosynthesis in rat vascular smooth muscle cells. J Vasc Res. 31:1994;144-152.
16. Venable M.E., Zimmerman G.A., McIntyre T.M., Prescott S.M. Platelet-activating factor: a phospholipid autacoid with diverse actions. J Lipid Res. 34:1993;691-702.
17. Wilson E.L., Rifkin D.B., Kelly F., Hannocks M.J., Gabrilove J.L. Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures. Blood. 77:1991;954-960.